Dennis Cantellops

FDA investigator

Appears on 10 documents from 2015 to 2024, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

10
Documents on file
4.1
Observations per 483
2015
First seen
2024
Most recent

What they cite most

From 35 observations

Activity by year

2015: 1, 2017: 1, 2018: 2, 2019: 1, 2022: 2, 2023: 2, 2024: 1

Where

India 3 · Japan 3 · China 2 · Italy 1 · Puerto Rico 1

Is Dennis Cantellops coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 FUJIMOTO CHEMICALS CO., LTD.Feb 7, 2024 · Amagasaki, Japan
483 Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai AvenueNov 21, 2023 · Nanchang City, China
483 NATCO PHARMA LIMITEDFeb 3, 2023 · Anakapalli, India
483 Steril-Gene Life Sciences Private LimitedNov 25, 2022 · Puducherry, India
483 Zhejiang Tianyu Pharmaceutical Co. LtdMar 4, 2022 · Taizhou City, China
483 TUBILUX PHARMA SPADec 10, 2019 · POMEZIA, Italy
483 Ono Pharmaceutical Co., Ltd.Dec 21, 2018 · FUJINOMIYA, Japan

About this profile

What does Dennis Cantellops inspect?

Dennis Cantellops appears on 10 documents on file covering 10 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.22 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Dennis Cantellops is dated Feb 7, 2024.

FDA Investigator Dennis Cantellops: 483s & Inspections · FDA Intel